Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
24th Feb 20262:25 pmRNSChange of Company Name
18th Feb 20262:12 pmRNSAppointment of Corporate Broker
6th Feb 20261:52 pmRNSDirector/PDMR Shareholding
2nd Feb 202611:02 amRNSTotal Voting Rights
6th Jan 20261:31 pmRNSDirector/PDMR Shareholding
2nd Jan 202611:06 amRNSTotal Voting Rights
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
12th Dec 20252:49 pmRNSBlock listing Return
8th Dec 202511:08 amRNSDirector/PDMR Shareholding
1st Dec 20251:57 pmRNSTotal Voting Rights
24th Nov 20255:20 pmRNSBlock Listing Application
24th Nov 20257:09 amRNSLIST 2025 Results Show Robust Capital Position
6th Nov 20253:47 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:01 pmRNSTotal Voting Rights
31st Oct 20253:10 pmRNSDirector/PDMR Shareholding
7th Oct 20251:20 pmRNSDirector/PDMR Shareholding
1st Oct 202512:38 pmRNSTotal Voting Rights
17th Sep 20252:40 pmRNSPublication of a Supplementary Prospectus
10th Sep 20252:51 pmRNSDirector/PDMR Shareholding
8th Sep 20255:23 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNS2025 Interim Results
1st Sep 202510:00 amRNSTotal Voting Rights
18th Aug 202510:00 amRNSBoard Changes
6th Aug 202512:53 pmRNSDirector/PDMR Shareholding
1st Aug 202510:18 amRNSTotal Voting Rights
8th Jul 20253:31 pmRNSDirector/PDMR Shareholding
1st Jul 202512:26 pmRNSTotal Voting Rights
26th Jun 20259:00 amRNSBoard Changes
13th Jun 20253:00 pmRNSPublication of Prospectus
12th Jun 20252:43 pmRNSBlock listing Return
9th Jun 202512:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:44 pmRNSTotal Voting Rights
23rd May 20253:02 pmRNSDirector/PDMR Shareholding
20th May 202510:00 amRNSDirector Declaration
13th May 20253:34 pmRNSResult of AGM
7th May 20254:20 pmRNSDirector/PDMR Shareholding
1st May 202510:33 amRNSTotal Voting Rights
10th Apr 20252:37 pmRNSDirector/PDMR Shareholding
8th Apr 20253:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20251:35 pmRNSNotice of AGM
1st Apr 20252:52 pmRNSDirector/PDMR Shareholding
1st Apr 20252:42 pmRNSTotal Voting Rights
26th Mar 20253:46 pmRNSDirector/PDMR Shareholding
24th Mar 20255:43 pmRNSDirector/PDMR Shareholding
21st Mar 202511:56 amRNSDirector/PDMR Shareholding
20th Mar 20254:19 pmRNSDirector/PDMR Shareholding
19th Mar 20254:26 pmRNSDirector/PDMR Shareholding
19th Mar 20252:15 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNS2024 Annual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.